LIPELLA PHARMACEUTICALS INC (LIPO) Stock Balance Sheet
NASDAQ:LIPO - Nasdaq - US53630L2097 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.35M | 3.29M | 5.12M | 1.41M | 606.70K | |||
| Marketable Securities | N/A | N/A | 0.00 | 300.60K | 0.00 | |||
| Receivables | 31.10K | 32.30K | 113.70K | 0.00 | 69.00K | |||
| Other Current Assets | 695.20K | 103.30K | 563.90K | 93.70K | 23.70K | |||
| Total Current Assets | 2.08M | 3.43M | 5.80M | 1.81M | 699.40K | |||
| Non-Current Assets | ||||||||
| PPE Net | 80.10K | 147.90K | 150.80K | 204.80K | 255.60K | |||
| Total Non-Current Assets | 80.10K | 147.90K | 150.80K | 204.80K | 255.60K | |||
| TOTAL ASSETS | 2.16M | 3.58M | 5.95M | 2.01M | 955.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 57.00K | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 275.00K | 25.00K | 25.00K | |||
| Accrued Expenses | 241.70K | 247.30K | 518.90K | 268.70K | 101.20K | |||
| Accounts Payable | 459.50K | 138.00K | 384.40K | 46.90K | 24.50K | |||
| Total Current Liabilities | 701.20K | 385.40K | 1.18M | 340.60K | 207.80K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 50.00K | 50.00K | |||
| Other Non-Current Liabilities | 0.00 | 47.40K | 96.30K | 198.70K | 233.90K | |||
| Total Non-Current Liabilities | 0.00 | 47.30K | 96.20K | 248.70K | 283.90K | |||
| TOTAL LIABILITIES | 701.20K | 432.70K | 1.27M | 589.30K | 491.70K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -13.90M | -10.32M | -5.70M | -3.11M | -1.24M | |||
| Additional Paid In Capital | 15.36M | 13.47M | 10.38M | 4.53M | 1.70M | |||
| Common Shares | 100.00 | 600.00 | 600.00 | 1.10K | 700.00 | |||
| Shares Outstanding | 1.09M | 756.70K | 718.00K | 718.00K | 5.74M | |||
| Tangible Book Value per Share | 1.34 | 4.16 | 6.51 | 1.98 | 0.08 | |||
| Total Shareholders' Equity | 1.46M | 3.14M | 4.68M | 1.42M | 463.30K | |||
| TOTAL LIABILITIES AND EQUITY | 2.16M | 3.58M | 5.95M | 2.01M | 955.00K | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.04 | 0.23 | |||
| Current Ratio | 2.97 | 8.90 | 4.92 | 5.31 | 3.37 | |||
| Return On Assets (ROA) | -197.38% | -129.12% | -43.66% | -92.68% | -6.46% | |||
| Return On Equity (ROE) | -292.24% | -146.89% | -55.56% | -131.04% | -13.32% | |||
All data in USD , ROIC based on taxRate of 0.21